GLPMGRSaxenda injection sites and dose steps: what the manufacturer says
This page lists where the manufacturer says Saxenda (liraglutide) can be injected in the UK, the EU and the US, and its dose steps and missed-dose wording, in their own words, with the documents each comes from. It is not medical advice.
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the shading shows where you've injected before. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.
Where Saxenda can be injected
Manufacturer: Novo Nordisk
United Kingdom
Areas listed:
- Front of waist (abdomen)
- Front of thigh
- Upper arm
Rotation, in the manufacturer’s words: “Change the place where you inject each day to reduce the risk of developing lumps.”
Source: MHRA products database / Novo Nordisk: Saxenda 6 mg/ml solution for injection in pre-filled pen, package leaflet (PLGB 04668/0409, last revised 08/2025), revised 08/2025. Checked 20 September 2026.
European Union
Areas listed:
- Abdomen
- Thigh
- Upper arm
Rotation, in the manufacturer’s words: “Change the place where you inject each day to reduce the risk of developing lumps.”
Source: EMA: Saxenda EPAR Product Information (English). Checked 20 September 2026.
United States
Areas listed:
- Abdomen
- Thigh
- Upper arm
Rotation, in the manufacturer’s words: “Change (rotate) your injection site with each injection.”
Source: FDA / DailyMed: Saxenda prescribing information and patient instructions (DailyMed, current label), revised 05/2025. Checked 20 September 2026.
Saxenda dose steps and missed doses
Most GLP-1 medicines start low and step up, which doctors call titration. This is what the Saxenda product information says, quoted word for word. UK wording comes from the patient leaflet; US wording from the prescribing information and Medication Guide. Your prescriber’s instructions come first, and GLPMGR never works out or recommends a dose.
United Kingdom
Dose steps, in the product information’s words:
- “When you first start using Saxenda, the starting dose is 0.6 mg once a day, for at least one week.”
- “Your doctor will instruct you to gradually increase your dose by 0.6 mg usually each week until you reach the recommended dose of 3.0 mg once a day.”
- “Week 1: 0.6 mg once a day. Week 2: 1.2 mg. Week 3: 1.8 mg. Week 4: 2.4 mg. Week 5 onwards: 3.0 mg once a day.”
- “Once you reach the recommended dose of 3.0 mg in week 5 of treatment, keep using this dose until your treatment period ends. Do not increase your dose further.”
If a dose is missed:
- “If you forget a dose and remember it within 12 hours from when you usually use the dose, inject it as soon as you remember.”
- “However, if more than 12 hours have passed since you should have used Saxenda, skip the missed dose and inject your next dose the following day at the usual time.”
- “Do not use a double dose or increase the dose on the following day to make up for the missed dose.”
Using it with another GLP-1 medicine: “Do not use Saxenda in combination with other medicines that contain GLP-1 receptor agonists (such as exenatide or lixisenatide).”
Source: MHRA / Novo Nordisk: Saxenda 6 mg/ml pre-filled pen package leaflet (PLGB 04668/0409), revised 08/2025. Checked 1 October 2026.
United States
Dose steps, in the product information’s words:
- “Week 1: 0.6 mg daily. Week 2: 1.2 mg. Week 3: 1.8 mg. Week 4: 2.4 mg. Week 5 and onward: 3 mg.”
- “For adults, the recommended dosage of SAXENDA is 3 mg daily, lower dosages are for titration only.”
- “If patients do not tolerate an increased dose during dosage escalation, consider delaying dosage escalation for approximately one additional week.”
If a dose is missed:
- “If you miss your daily dose of SAXENDA, just take your next daily dose as usual on the following day. Do not take an extra dose of SAXENDA or increase your dose on the following day to make up for your missed dose.”
- “If you miss your dose of SAXENDA for 3 days or more, call your healthcare provider to talk about how to restart your treatment.”
Using it with another GLP-1 medicine: “Coadministration with other liraglutide-containing products or with any other glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.”
Source: FDA / Novo Nordisk: Saxenda prescribing information and Medication Guide, DailyMed, effective 02/2026. Checked 27 September 2026.
In GLPMGR, enter the dose steps your prescriber gave you and it fills in the right dose each time you log. The same wording is in the app, under Dose Steps & Missed Doses.
Track your Saxenda doses and injection sites in GLPMGR
GLPMGR is a private GLP-1 tracker for iPhone, iPad and Apple Watch. Choose Saxenda when you record a dose and it offers only the areas above for your region, shows a body map of where you have injected before, and shows the manufacturer’s rotation wording. It also follows your dose steps, reminds you when a dose is due, and keeps a note of side effects. It does not tell you where to inject, and it is independent of Novo Nordisk.
Other medicines with the same active ingredient:
Medical disclaimer
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the shading shows where you've injected before. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.